We constructed a risk model based on the expression levels of these RBPs and found that ADAT2, C2orf15, SRP72, PAICS, RBMS3, APOBEC3G, NOA1, and ACO1 could be used for risk assessment in terms of breast cancer prognosis (Fig. 4A–C). This evidence concerns the gene RBMS3 and breast carcinoma.